Effects of Non-invasive Brain Stimulation in Tobacco Use Disorder

NCT ID: NCT02776319

Last Updated: 2016-05-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-05-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the study is to determine the effect of non-invasive brain stimulation on craving for tobacco and brain metabolites.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active

Non-invasive brain stimulation (active)

Group Type EXPERIMENTAL

Non-invasive brain stimulation (active)

Intervention Type DEVICE

Non-invasive brain stimulation (active)

Sham/Placebo

Non-invasive brain stimulation (sham)

Group Type PLACEBO_COMPARATOR

Non-invasive brain stimulation (sham)

Intervention Type DEVICE

Non-invasive brain stimulation (sham)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-invasive brain stimulation (active)

Non-invasive brain stimulation (active)

Intervention Type DEVICE

Non-invasive brain stimulation (sham)

Non-invasive brain stimulation (sham)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Tobacco use disorder (DSM-V)

Exclusion Criteria

* Other psychiatric disorders
* Contraindication to non-invasive brain stimulation and MRI
Minimum Eligible Age

21 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laval University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shirley Fecteau

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Social

Québec, Quebec, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Antoine Hone-Blanchet, MSC

Role: CONTACT

4185299141 ext. 2460

Shirley Fecteau, PHD

Role: CONTACT

4185299141 ext. 6121

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-465

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

tDCS Plus Varenicline for Smoking Cessation
NCT06798324 RECRUITING PHASE4
Accelerated dTMS Smoking Cessation
NCT07292883 NOT_YET_RECRUITING PHASE2
The Use of TDCS for Vaping Reduction
NCT06885606 NOT_YET_RECRUITING NA
The Effects of Sedatives on Tobacco Use Disorder
NCT03813121 COMPLETED PHASE1/PHASE2